Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

NCT06011551 is registered in ClinicalTrials.gov with ReGelTec, Inc. as lead sponsor.

NCT NCT06011551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06011551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Lead sponsor
ReGelTec, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
January 13, 2025
Completion date
December 31, 2028
Enrollment
225 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease (ddd)